AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-20169165_ITM" title="Facts and information about ICOS to Participate in Upcoming Healthcare Conference.">ICOS to Participate in Upcoming Healthcare Conference.</a>
Close
Set up an RSS feed that alerts you when new articles from Business Wire are available.
Frequently asked questions about RSS feeds
ICOS to Participate in Upcoming Healthcare Conference.
Business Editors/Health/Medical Writers
Merrill Lynch Global Pharmaceuticals, Medical Device &
Biotechnology Conference
BOTHELL, Wash.--(BUSINESS WIRE)--Jan. 30, 2004
ICOS Corporation (Nasdaq:ICOS) announced today that it will participate in the Merrill Lynch Global Pharmaceuticals, Medical Device & Biotechnology Conference on February 5, 2004.
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- ICOS to Participate in Merrill Lynch Global Pharmaceutical, Biotechnology and...
- Press release article from: Business Wire January 27, 2003 700+ words
...BUSINESS WIRE)--Jan. 27, 2003 ICOS Corporation (Nasdaq:ICOS) announced today that Paul N...President, will speak at the Merrill Lynch Global Pharmaceutical, Biotechnology...webcast can be accessed through the ICOS website, www.icos.com...
- ICOS Scheduled at Merrill Lynch Pharmaceutical, Biotechnology & Medical Device...
- Press release article from: Business Wire February 1, 2002 700+ words
...Writers BOTHELL, Wash.--(BW HealthWire)--Feb. 1, 2002 ICOS Corporation (Nasdaq:ICOS) announced today that Paul Clark, ICOS Chairman and CEO, will speak at the Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference...
- ICOS Announces Revised Merger Agreement With Lilly.
- Press release article from: Business Wire December 18, 2006 700+ words
...been significant trading volume in ICOS' common stock. A new proxy statement...the amended agreement, a copy of Merrill Lynch's fairness opinion and related...Sutcliffe LLP acted as legal advisors to ICOS in connection with the transaction...
- ICOS to Participate in Upcoming Healthcare Conference.
- Press release article from: Business Wire January 25, 2005 700+ words
...BOTHELL, Wash. -- ICOS Corporation (Nasdaq:ICOS) announced today...participate in the Merrill Lynch Global Pharmaceuticals...February 8, 2005. Merrill Lynch Conference Presentation...A webcast of this ICOS presentation will...
- ICOS to Participate in Upcoming Investment Conference.
- Press release article from: Business Wire January 24, 2006 700+ words
...BOTHELL, Wash. -- ICOS Corporation (Nasdaq:ICOS) announced today...participate in the Merrill Lynch Global Pharmaceutical...will be webcast. Merrill Lynch Conference Presentation...A webcast of this ICOS presentation will...
- ICOS Corporation Announces Agreement to be Acquired by Eli Lilly and Company.
- Press release article from: Business Wire October 17, 2006 700+ words
...beginning operations in 1990, ICOS has focused on significant...approval by the shareholders of ICOS and other customary closing conditions. Merrill Lynch & Co. acted as financial...LLP acted as legal advisor to ICOS in connection with the transaction...
- ICOS Special Meeting Adjourned and Scheduled to January 25, 2007.
- Press release article from: Business Wire December 19, 2006 700+ words
...ICOS Corporation (NASDAQ: ICOS) announced that its special...outstanding common stock of ICOS for a purchase price of...amended agreement, a copy of Merrill Lynch's fairness opinion and related disclosures. About ICOS Corporation: ICOS Corporation...
- ICOS GETS $313.5M OFFERING THROUGH, DESPITE TIGHT MARKET.(Biotechnology firm's...
- Magazine article from: BIOWORLD Today Huggett, Brady November 9, 2001 700+ words
...raised through public offerings - ICOS Corp. pulled off the largest...Boston Corp., of New York, and Merrill Lynch, Pierce, Fenner & Smith...places Bothell, Wash.-based ICOS at the top of the biotechnology...period in 2000. An offering of ICOS' size in this stingy atmosphere...
